Provide guidance and strategic counsel with regard to regulations and legislation that could impact the biopharmaceutical industry generally such as drug pricing and telehealth policy
2026 · 3rd Quarter (July 1 - Sep 30)
NEUROCRINE BIOSCIENCES, INC.
Filed by BGR GOVERNMENT AFFAIRS.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- BGR GOVERNMENT AFFAIRS
- Filing UUID
- 2e79db6a-4b1d-41f9-9d08-1ac90d2e16a0
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.